Navitas Life Sciences has been supporting efficient clinical trials for over 30 years, partnering with small to large pharmaceuticals, Life Sciences companies and U.S.Federal agencies to bring life-saving medicines to the market. Transforming health and healthcare has been a priority and supporting patient needs begins even before trial initiation.
The global COVID-19 pandemic has raised awareness about the relevance of clinical research but has also brought in certain changes to the way clinical trials are run, like decentralized clinical trials and virtual clinical trials. Navitas Life Sciences has been quick to adapt to the evolving patient needs and to ensure stellar patient experience throughout.
5 ways Navitas Life Sciences has ensured better patient Experience during Clinical Trials
Navitas Life Sciences has more than 25000 healthy volunteers, with 700 post-menopausal women, and patients with cancer, diabetes, hypertension and renal disease. This has aided in recruiting study participants during the pandemic, ensuring that milestones were adhered to at all times.
5 Ps to Enhanced Patient Experience with Navitas Life Sciences
- Patient Awareness
- Patient Centricity
- Patient Comfort
- Patient Engagement
- Patient Safety
1) Patient Awareness- Detailing all aspects of the study: Patients and volunteers of the study are made to understand the full journey that they will be a part of. By explaining the entire process, doctors and patients understand the various stages, with key insights provided by the patients at various junctures.
2) Patient Centricity during Study Design: The needs of the patients and the support required is included in the study design. A single procedure may not be a cause of discomfort for the patient, but when it is coupled with stringent regimens, it can be a cause of discomfort, if it hasn’t been well planned out.
For example, a blood sample collection may not be a cause of concern, unless there are multiple samples to be collected at specific intervals. This requires effective support for transportation, food, or even a place to stay, so that study participants have limited discomfort. A well thought out plan, with patient experience in mind help in tailoring suitable supporting measures, even before the start of the study.
Patient centricity is a focus not only for patients who take part in the study but Is a focus for the multiple patients who will use the drug product when it reaches the market.
3) Patient Comfort- Participating from home! Navitas Life Sciences has always been sensitive to the needs of patients, which includes transportation to sites. To ensure patient comfort, trial sites that are closer to patients are normally selected for the study.
With rapid decentralization of clinical trials during the pandemic and beyond, patients are treated and evaluated from the comfort of their home. This has helped in elevating patient experience and supported improved patient retention. In-house care was always supported for patients who were too ill to travel.
4) Patient Engagement with digital tools: Patient health forms and e-consent forms were obtained using digital tools, which meant that patients could now sign up for the clinical trials without multiple trips to the site. Moreover, telemedicine was used to check on participants, whenever possible, to manage COVID-19 mediated restrictions or to support patients who needed it.
The digital tools are also used to engage with patients better, and to provide them with the assistance they need. This has improved interactions with patients and helped address their concerns.
5) Patient Safety during the pandemic and beyond: Patient safety has always been a priority at Navitas Life Sciences. Sites that were close to patient homes were selected, to reduce the risk of infection during the pandemic. Study participants were tested routinely for COVID-19 and all participants were checked for symptoms. High risk patients, like oncology patients, were asked to stay home, with home doctor visits facilitated. COVID-19 vaccination has been actively advocated, with most research staff vaccinated.
In the most complete articulation, Patients and volunteers who participate in our studies are the prime focus, with the extension of the right resources and technologies to ensure smooth transition through the clinical trial.